Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

US Innovative Healthcare Ishares Evolved ETF (IEIH)

US Innovative Healthcare Ishares Evolved ETF (IEIH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 22,830,000
  • Market Capitalization, $K 22,830
  • Shares Outstanding, K 750
  • 60-Month Beta 0.77
  • Price/Earnings ttm 19.84
  • Annual Dividend & Yield 0.86 (2.82%)
  • Most Recent Dividend 0.063 on 06/15/20
  • Management Fee 0.18%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.73 +0.74%
on 07/31/20
31.85 -5.97%
on 07/20/20
-0.39 (-1.29%)
since 07/10/20
3-Month
27.81 +7.69%
on 06/15/20
31.85 -5.97%
on 07/20/20
+0.18 (+0.62%)
since 05/11/20
52-Week
22.07 +35.70%
on 03/23/20
31.85 -5.97%
on 07/20/20
+5.04 (+20.25%)
since 08/09/19

Most Recent Stories

More News
Coronavirus Makes Biotech ETFs Red Hot

The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic.

REGN : 598.86 (-1.54%)
PFE : 37.79 (-1.56%)
GILD : 68.10 (-0.60%)
MRNA : 68.97 (-4.22%)
ABT : 99.06 (-0.98%)
AMGN : 234.65 (-1.48%)
TMO : 407.24 (-0.71%)
IBB : 131.88 (-2.22%)
INO : 14.62 (-23.01%)
BBH : 159.08 (-1.55%)
FBT : 162.26 (-1.39%)
ARKG : 56.25 (-3.60%)
IEIH : 29.95 (-1.74%)
BNTX : 68.45 (-7.44%)
JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus

Investors should closely watch the movement of the stock and keep a close eye on ETFs having double-digit allocation to this diversified drug maker post its earnings release.

JNJ : 146.97 (-0.72%)
XLV : 105.38 (-0.63%)
VHT : 202.19 (-0.98%)
IYH : 226.35 (-0.74%)
IHE : 161.38 (-1.25%)
IEIH : 29.95 (-1.74%)
Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas

Warren Buffett took positions in Biogen and Kroger. Investors who want to follow Buffett's picking of these two value stocks can also play these ETFs as well.

BIIB : 289.94 (-3.44%)
AMZN : 3,080.67 (-2.14%)
WMT : 130.20 (-1.27%)
KR : 34.26 (-2.20%)
IBB : 131.88 (-2.22%)
BBH : 159.08 (-1.55%)
FTXD : 25.51 (-0.18%)
FXG : 48.99 (-0.93%)
IEIH : 29.95 (-1.74%)
JNJ Beats, Ups View: Healthcare ETFs to Buy

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

JNJ : 146.97 (-0.72%)
XLV : 105.38 (-0.63%)
IYH : 226.35 (-0.74%)
IHE : 161.38 (-1.25%)
VHT : 202.19 (-0.98%)
IEIH : 29.95 (-1.74%)
Amgen to Buy Celgene's Otezla: 5 ETF Drugs

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

NVS : 82.43 (+0.05%)
BMY : 63.13 (+2.12%)
BBH : 159.08 (-1.55%)
PJP : 65.42 (-1.62%)
IBB : 131.88 (-2.22%)
PBE : 59.03 (-2.02%)
CELG : 108.24 (+0.10%)
AMGN : 234.65 (-1.48%)
IEIH : 29.95 (-1.74%)
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

JNJ : 146.97 (-0.72%)
IHE : 161.38 (-1.25%)
XLV : 105.38 (-0.63%)
IYH : 226.35 (-0.74%)
VHT : 202.19 (-0.98%)
IEIH : 29.95 (-1.74%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 105.38 (-0.63%)
VHT : 202.19 (-0.98%)
IHE : 161.38 (-1.25%)
IYH : 226.35 (-0.74%)
IEIH : 29.95 (-1.74%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 105.38 (-0.63%)
VHT : 202.19 (-0.98%)
IHE : 161.38 (-1.25%)
IYH : 226.35 (-0.74%)
IEIH : 29.95 (-1.74%)
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

QCLN : 37.60 (-2.54%)
ITA : 172.14 (+0.53%)
BTEC : 44.11 (-2.96%)
CNCR : 25.89 (-1.62%)
XLP : 63.40 (-0.69%)
GNRX : 22.42 (-0.06%)
BBC : 40.39 (-3.65%)
EWW : 33.82 (+0.89%)
PBW : 51.70 (-2.51%)
XAR : 93.63 (+0.72%)
MOO : 66.79 (+0.75%)
CARZ : 36.58 (+1.87%)
PPA : 58.91 (+0.65%)
IEIH : 29.95 (-1.74%)
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

QCLN : 37.60 (-2.54%)
ITA : 172.14 (+0.53%)
BTEC : 44.11 (-2.96%)
CNCR : 25.89 (-1.62%)
XLP : 63.40 (-0.69%)
GNRX : 22.42 (-0.06%)
BBC : 40.39 (-3.65%)
EWW : 33.82 (+0.89%)
PBW : 51.70 (-2.51%)
XAR : 93.63 (+0.72%)
MOO : 66.79 (+0.75%)
CARZ : 36.58 (+1.87%)
PPA : 58.91 (+0.65%)
IEIH : 29.95 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IEIH with:

Fund Summary

The iShares Evolved U.S. Innovative Healthcare ETF seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system.

See More

Key Turning Points

2nd Resistance Point 30.52
1st Resistance Point 30.24
Last Price 29.95
1st Support Level 29.81
2nd Support Level 29.66

See More

52-Week High 31.85
Last Price 29.95
Fibonacci 61.8% 28.11
Fibonacci 50% 26.96
Fibonacci 38.2% 25.81
52-Week Low 22.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar